SCHEMBL26980972

SCHEMBL26980972

NC(Cc1ccc(CCl)c(CCl)c1)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 5/20 0.58
SLC7A5 Q01650 4/20 0.58
PTGS1 P23219 3/20 0.58
ALOX15 P16050 3/20 0.58
KDM4E B2RXH2 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
USP2 O75604 1/20 0.58
EGFR P00533 1/20 0.58
LCK P06239 1/20 0.58
FYN P06241 1/20 0.58
ADORA3 P0DMS8 1/20 0.58
HTR2A P28223 1/20 0.58
PTGS2 P35354 1/20 0.58
RECQL P46063 1/20 0.58
HSD17B10 Q99714 1/20 0.58
PKM P14618 2/20 0.53
ALPI P09923 1/20 0.53
XIAP P98170 1/20 0.53
CYP3A4 P08684 3/20 0.51
ALDH1A1 P00352 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30004590 1.00 HIF1A (0.58) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL26980959 1.00 HIF1A (0.58) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL3981521 0.87 SLC7A5 (0.69) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL3279504 0.81 SLC7A5 (0.60) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL9316604 0.81 SLC7A5 (0.60) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL9316537 0.81 SLC7A5 (0.60) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL3277307 0.81 SLC7A5 (0.60) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL3277300 0.81 SLC7A5 (0.60) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL29101090 0.80 SLC7A5 (0.69) HIF1ASLC7A5PTGS1ALOX15KDM4E
SCHEMBL2779304 0.80 SLC7A5 (0.69) HIF1ASLC7A5PTGS1ALOX15KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11866518-B2 Bicyclic peptide ligands specific for TSLP BICYCLETX LIMITED (GB) 2024-01-09 US disclosed
CN-115768456-A TSLP-specific bicyclic peptide ligands 拜斯科技术开发有限公司 2023-03-07 CN disclosed
US-20220363718-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TSLP BICYCLETX LIMITED (GB) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363718-A1 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TSLP TSLP, VIP, CCL2 HIF1A 2096/4885SLC7A5 3749/4885PTGS1 1171/4885
US-11866518-B2 Bicyclic peptide ligands specific for TSLP TSLP, VIP, CCL2 HIF1A 2096/4885SLC7A5 3749/4885PTGS1 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.